Companies: 10,795·Total market cap: $144.5T
DexCom, Inc.

DexCom, Inc.

DXCMNASDAQHealthcare● Active
$72.86
+$0.27(+0.37%)
Market Cap$28.1B
P/E Ratio
52W High$89.98
52W Low$54.11

DexCom, Inc. (DXCM) · Income Statement

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · DXCM · as of 2026-06-08

Financial statements

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$4.66B$4.03B$3.62B$2.91B$2.45B
Cost of Revenue$1.86B$1.59B$1.33B$1.03B$0.77B
Gross Profit$2.80B$2.44B$2.29B$1.88B$1.68B
Gross Margin %(computed)60.01%60.46%63.19%64.72%68.63%
Operating Expenses
R&D Expenses$0.59B$0.55B$0.51B$0.48B$0.60B
G&A Expenses$0.00B$0.00B$0.00B$0.00B$0.00B
Total Operating Expenses$1.89B$1.84B$1.69B$1.49B$1.41B
Operating Income$0.91B$0.60B$0.60B$0.39B$0.27B
Operating Margin %(computed)19.56%14.88%16.50%13.44%10.86%
Interest Income$0.11B$0.13B$0.14B$0.02B$0.00B
Interest Expense$0.02B$0.02B$0.02B$0.02B$0.02B
Income Before Tax$1.09B$0.71B$0.71B$0.39B$0.26B
Income Tax Expense$0.25B$0.13B$0.17B$0.05B$0.04B
Net Income$0.84B$0.58B$0.54B$0.34B$0.22B
Net Margin %(computed)17.94%14.29%14.95%11.73%8.86%
Per Share & EBITDA
EPS (Basic)$2.14$1.46$1.44$0.88$0.56
Wtd Avg Shares0.39B0.40B0.39B0.39B0.39B
EBITDA$1.16B$0.95B$0.92B$0.57B$0.38B
EBITDA Margin %(computed)24.96%23.45%25.31%19.43%15.42%

Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B

Explore more DexCom, Inc. data

About DexCom, Inc. (DXCM) Income Statement

DexCom, Inc. (DXCM) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, DXCM reported revenue of $4.66B, gross profit of $2.80B (gross margin 60.01%), and net income of $0.84B — a net profit margin of 17.94%.

Frequently asked questions

DXCM · 4 questions

DexCom, Inc. (DXCM) reported revenue of $4.66B for 2025, up 15.6% year-over-year.

DXCM revenueDXCM salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08